SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-118266
Filing Date
2016-05-05
Accepted
2016-05-05 16:01:49
Documents
39
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6505_110q.htm 10-Q 938446
2 EX-31.1 a16-6505_1ex31d1.htm EX-31.1 11146
3 EX-31.2 a16-6505_1ex31d2.htm EX-31.2 11166
4 EX-32.1 a16-6505_1ex32d1.htm EX-32.1 5242
5 EX-32.2 a16-6505_1ex32d2.htm EX-32.2 5267
  Complete submission text file 0001104659-16-118266.txt   4107611

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20160331.xml EX-101.INS 1048216
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20160331.xsd EX-101.SCH 23619
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20160331_cal.xml EX-101.CAL 35784
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20160331_def.xml EX-101.DEF 73542
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gern-20160331_lab.xml EX-101.LAB 252238
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20160331_pre.xml EX-101.PRE 161656
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 161623563
SIC: 2834 Pharmaceutical Preparations